skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Six months of Herceptin could be as effective as 12 months for some women with early-stage breast cancer

Six months of Herceptin could be as effective as 12 months for some women with early-stage breast cancer

18 May 2018

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research. We are confident that this will mark the first steps towards a reduction of Herceptin treatment to six months in many...


Read more at: Professor Lynn Gladden named Executive Chair of Engineering and Physical Sciences Research Council

Professor Lynn Gladden named Executive Chair of Engineering and Physical Sciences Research Council

8 May 2018

Professor Lynn Gladden CBE, FRS, FREng has been selected to be the next Executive Chair of the Engineering and Physical Sciences Research Council (EPSRC), as announced today by Science Minister Sam Gyimah. She will take up the role in October, succeeding Professor Philip Nelson who will step down at the end of September...


Read more at: New Department of Chemical Engineering and Biotechnology building officially opened by the Chancellor

New Department of Chemical Engineering and Biotechnology building officially opened by the Chancellor

25 April 2018

This new building in Cambridge will house the science stars of the future The science stars of tomorrow will be nurtured in a brand new building which has opened at the West Cambridge site. Cambridge University's department of chemical engineering and biotechnology's new base will provide whole cycle of scientific...


Read more at: Unique science for health policy think-tank joins University of Cambridge

Unique science for health policy think-tank joins University of Cambridge

29 March 2018

Unique science for health policy think-tank joins University of Cambridge A leading multidisciplinary think tank, the PHG Foundation, will become part of the University of Cambridge from 1 April this year, with a focus on making science work for health. This has been made possible by a philanthropic gift from the Hong Kong...


Read more at: Looking to Disrupt Healthcare? Enter the MedImmune Digital Health Challenge

Looking to Disrupt Healthcare? Enter the MedImmune Digital Health Challenge

29 March 2018

Looking to Disrupt Healthcare? Enter the MedImmune Digital Health Challenge Choose from a list of six topics and submit your best solution! Mhealth solution for measuring of disease progression in chronic respiratory disease - open to highly novel endpoints e.g. socialisation Data mining of eHealth records to aid focussed...


Read more at: The body in miniature

The body in miniature

21 March 2018

The Body in Miniature The past few years has seen an explosion in the number of studies using organoids – so-called ‘mini organs’. While they can help scientists understand human biology and disease, some in the field have questioned their usefulness. But as the field matures, we could see their increasing use in...


Read more at: Study in mice suggests personalised stem cell treatment may offer relief for progressive MS

Study in mice suggests personalised stem cell treatment may offer relief for progressive MS

15 March 2018

Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS). Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to...


Read more at: Cambridge University and Institute of Cancer Research launch Children’s Brain Tumour Centre of Excellence

Cambridge University and Institute of Cancer Research launch Children’s Brain Tumour Centre of Excellence

15 March 2018

Cancer Research UK (CRUK) has recently announced funding for a new Children’s Brain Tumour Centre of Excellence, based at the University of Cambridge and The Institute of Cancer Research, London. By creating a hub of expertise for childhood brain tumour research in the UK, we aim to make real inroads to tackling these...


Read more at: Cambridge establishes strategic partnership with Pfizer under new model for promoting collaborative research

Cambridge establishes strategic partnership with Pfizer under new model for promoting collaborative research

9 January 2018

The University of Cambridge is among the first three institutions to join Pfizer's Innovative Target Exploration Network (ITEN) programme. Announced by Pfizer on 8th January, ITEN is a new, early-stage partnering model that enables collaborative relationships with select academic institutions and principal investigators...


Read more at: Cambridge Academy of Therapeutic Sciences receives Wellcome funding to support translational research

Cambridge Academy of Therapeutic Sciences receives Wellcome funding to support translational research

7 December 2017

The Cambridge Academy of Therapeutic Sciences (CATS) has been awarded £1million over two years by Wellcome as a part of a new scheme to find new ways to translate scientific discoveries into real world impact. Cambridge is one six institutions to receive funding to create partnerships with Wellcome. The others are the...